A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor

He Zhou1, Yunping Luo, Charles D Kaplan

  • 1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA 92037, USA.

Blood
|December 22, 2005
PubMed

Insights

This study shows a dual-function DNA vaccine enhances antitumor immunity by improving crosstalk between immune cells. It activates NK cells and CD8 T cells while reducing suppressive CD4 T cells for better tumor protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Cancer Research

Background:

  • The NKG2D receptor is crucial for activating NK cells and CD8 T cells.
  • Previous work showed NKG2D receptor engagement improves DNA vaccine efficacy.
  • A combined vaccine encoding H60 and survivin enhances antitumor immunity.

Purpose of the Study:

  • To investigate the mechanisms behind the enhanced efficacy of the pH60/Survivin DNA vaccine.
  • To elucidate the roles of CD8 T cells, NK cells, and CD4 T cells in vaccine-induced antitumor immunity.

Main Methods:

  • Utilizing a dual-function DNA vaccine encoding NKG2D ligand H60 and survivin.
  • Employing lymphocyte depletion strategies (CD8 T cells, NK cells, CD4 T cells) during vaccine priming.
  • Assessing immune cell activation (dendritic cells, NK cells, CD8 T cells, CD4 T cells) and homing patterns.

Main Results:

  • Depletion of CD8 T cells or NK cells impaired vaccine-induced DC and lymphocyte activation.
  • Depletion of CD4 T cells enhanced DC, NK cell, and CD8 T cell activation, alongside increased NK cell activity.
  • The pH60/Survivin vaccine promoted DC and NK cell increases but decreased CD4 T cell homing to Peyer patches.

Conclusions:

  • Enhanced vaccine efficacy is partly due to improved lymphocyte crosstalk.
  • The vaccine modulates immune cell populations, favoring activation of antitumor effectors.
  • The dual-function DNA vaccine creates a favorable microenvironment for NK cell activation and T cell priming, reducing negative regulators.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...